IDYA: Ideaya Biosciences Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Ideaya Biosciences Inc (IDYA).
$2.22B Market Cap.
IDYA Market Cap. (MRY)
IDYA Shares Outstanding (MRY)
IDYA Assets (MRY)
Total Assets
$1.12B
Total Liabilities
$64.94M
Total Investments
$997.77M
IDYA Income (MRY)
Revenue
$7.00M
Net Income
-$274.48M
Operating Expense
$333.98M
IDYA Cash Flow (MRY)
CF Operations
-$247.58M
CF Investing
-$502.56M
CF Financing
$677.55M
IDYA Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $1,124,091,000 (73.12%) | $649,316,000 (67.36%) | $387,969,000 (1.74%) | $381,347,000 (27.85%) |
Assets Current | $689,713,000 (29.49%) | $532,632,000 (43.78%) | $370,454,000 (47.59%) | $250,996,000 (-13.03%) |
Assets Non-Current | $434,378,000 (272.27%) | $116,684,000 (566.19%) | $17,515,000 (-86.56%) | $130,351,000 (1248.83%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $1,059,147,000 (70.53%) | $621,090,000 (77.73%) | $349,455,000 (15.90%) | $301,514,000 (52.07%) |
Property Plant & Equipment Net | $27,741,000 (229.86%) | $8,410,000 (-6.48%) | $8,993,000 (3.83%) | $8,661,000 (-8.60%) |
Cash & Equivalents | $85,183,000 (-46.01%) | $157,775,000 (129.53%) | $68,738,000 (-25.41%) | $92,152,000 (27.74%) |
Accumulated Other Comprehensive Income | $812,000 (44.48%) | $562,000 (119.58%) | -$2,871,000 (-303.23%) | -$712,000 (-10271.43%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $997,773,000 (109.80%) | $475,588,000 (56.18%) | $304,514,000 (10.32%) | $276,017,000 (30.47%) |
Investments Current | $591,941,000 (60.81%) | $368,096,000 (24.27%) | $296,197,000 (91.44%) | $154,724,000 (-26.86%) |
Investments Non-Current | $405,832,000 (277.55%) | $107,492,000 (1192.44%) | $8,317,000 (-93.14%) | $121,293,000 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $18,000 (-91.47%) | $211,000 (-80.87%) | $1,103,000 (-41.24%) |
Trade & Non-Trade Payables | $15,421,000 (133.72%) | $6,598,000 (54.16%) | $4,280,000 (103.81%) | $2,100,000 (120.36%) |
Accumulated Retained Earnings (Deficit) | -$622,841,000 (-78.79%) | -$348,364,000 (-47.99%) | -$235,403,000 (-33.19%) | -$176,748,000 (-39.19%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $19,171,000 (567.51%) | $2,872,000 (-17.52%) | $3,482,000 (-32.79%) | $5,181,000 (-22.94%) |
Debt Current | $298,000 (-82.94%) | $1,747,000 (-6.63%) | $1,871,000 (10.12%) | $1,699,000 (10.32%) |
Debt Non-Current | $18,873,000 (1577.60%) | $1,125,000 (-30.17%) | $1,611,000 (-53.73%) | $3,482,000 (-32.82%) |
Total Liabilities | $64,944,000 (130.09%) | $28,226,000 (-26.71%) | $38,514,000 (-51.76%) | $79,833,000 (-20.16%) |
Liabilities Current | $46,071,000 (70.00%) | $27,101,000 (-14.56%) | $31,718,000 (-29.76%) | $45,159,000 (16.87%) |
Liabilities Non-Current | $18,873,000 (1577.60%) | $1,125,000 (-83.45%) | $6,796,000 (-80.40%) | $34,674,000 (-43.49%) |
IDYA Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $7,000,000 (-70.07%) | $23,385,000 (-54.08%) | $50,931,000 (82.28%) | $27,941,000 (43.01%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $39,302,000 (38.85%) | $28,306,000 (18.45%) | $23,897,000 (19.18%) | $20,051,000 (32.05%) |
Research & Development Expense | $294,673,000 (127.53%) | $129,508,000 (44.64%) | $89,536,000 (53.95%) | $58,158,000 (46.50%) |
Operating Expenses | $333,975,000 (111.63%) | $157,814,000 (39.13%) | $113,433,000 (45.04%) | $78,209,000 (42.50%) |
Interest Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$274,477,000 (-142.98%) | -$112,961,000 (-92.59%) | -$58,655,000 (-17.87%) | -$49,762,000 (-44.26%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$274,477,000 (-142.98%) | -$112,961,000 (-92.59%) | -$58,655,000 (-17.87%) | -$49,762,000 (-44.26%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$274,477,000 (-142.98%) | -$112,961,000 (-92.59%) | -$58,655,000 (-17.87%) | -$49,762,000 (-44.26%) |
Weighted Average Shares | $81,678,069 (42.00%) | $57,519,929 (38.79%) | $41,444,696 (17.57%) | $35,252,443 (42.60%) |
Weighted Average Shares Diluted | $81,678,069 (42.00%) | $57,519,929 (38.79%) | $41,444,696 (17.57%) | $35,252,443 (42.60%) |
Earning Before Interest & Taxes (EBIT) | -$274,477,000 (-142.98%) | -$112,961,000 (-92.59%) | -$58,655,000 (-17.87%) | -$49,762,000 (-44.26%) |
Gross Profit | $7,000,000 (-70.07%) | $23,385,000 (-54.08%) | $50,931,000 (82.28%) | $27,941,000 (43.01%) |
Operating Income | -$326,975,000 (-143.23%) | -$134,429,000 (-115.08%) | -$62,502,000 (-24.34%) | -$50,268,000 (-42.22%) |
IDYA Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$502,559,000 (-217.16%) | -$158,456,000 (-374.36%) | -$33,404,000 (52.05%) | -$69,666,000 (52.36%) |
Net Cash Flow from Financing | $677,551,000 (86.80%) | $362,717,000 (273.30%) | $97,165,000 (-33.20%) | $145,454,000 (12.97%) |
Net Cash Flow from Operations | -$247,584,000 (-114.87%) | -$115,224,000 (-32.18%) | -$87,175,000 (-56.29%) | -$55,779,000 (-200.57%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$72,592,000 (-181.53%) | $89,037,000 (480.27%) | -$23,414,000 (-217.02%) | $20,009,000 (-47.30%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | -$498,702,000 (-219.50%) | -$156,088,000 (-420.97%) | -$29,961,000 (55.30%) | -$67,022,000 (54.02%) |
Capital Expenditure | -$3,857,000 (-62.88%) | -$2,368,000 (31.22%) | -$3,443,000 (-30.22%) | -$2,644,000 (-436.31%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $668,151,000 (108.45%) | $320,535,000 (229.89%) | $97,165,000 (-33.20%) | $145,454,000 (12.97%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $34,746,000 (87.93%) | $18,489,000 (58.99%) | $11,629,000 (41.18%) | $8,237,000 (128.23%) |
Depreciation Amortization & Accretion | $3,834,000 (-4.34%) | $4,008,000 (14.03%) | $3,515,000 (15.93%) | $3,032,000 (119.55%) |
IDYA Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 100.00% (0.00%) | 100.00% (0.00%) | 100.00% (0.00%) | 100.00% (0.00%) |
Profit Margin | -3921.10% (-711.82%) | -483.00% (-319.27%) | -115.20% (35.32%) | -178.10% (-0.85%) |
EBITDA Margin | -3866.30% (-729.86%) | -465.90% (-330.19%) | -108.30% (35.23%) | -167.20% (1.36%) |
Return on Average Equity (ROAE) | -26.70% (-16.09%) | -23.00% (-25.00%) | -18.40% (-1.10%) | -18.20% (13.74%) |
Return on Average Assets (ROAA) | -25.50% (-16.97%) | -21.80% (-38.85%) | -15.70% (-12.95%) | -13.90% (10.90%) |
Return on Sales (ROS) | -3921.10% (-711.82%) | -483.00% (-319.27%) | -115.20% (35.32%) | -178.10% (-0.85%) |
Return on Invested Capital (ROIC) | -32.20% (-6.62%) | -30.20% (-36.04%) | -22.20% (2.63%) | -22.80% (22.71%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -7.65 (57.86%) | -18.15 (-41.86%) | -12.8 (23.68%) | -16.77 (-67.66%) |
Price to Sales Ratio (P/S) | 299.88 (242.65%) | 87.52 (491.88%) | 14.79 (-50.43%) | 29.83 (68.38%) |
Price to Book Ratio (P/B) | 2.1 (-43.22%) | 3.69 (47.60%) | 2.5 (-17.10%) | 3.02 (47.00%) |
Debt to Equity Ratio (D/E) | 0.06 (35.56%) | 0.04 (-59.09%) | 0.11 (-58.49%) | 0.27 (-47.42%) |
Earnings Per Share (EPS) | -3.36 (-71.43%) | -1.96 (-38.03%) | -1.42 (-0.71%) | -1.41 (-0.71%) |
Sales Per Share (SPS) | 0.09 (-78.87%) | 0.41 (-66.88%) | 1.23 (54.98%) | 0.79 (0.38%) |
Free Cash Flow Per Share (FCFPS) | -3.08 (-50.59%) | -2.04 (6.50%) | -2.19 (-31.93%) | -1.66 (-174.51%) |
Book Value Per Share (BVPS) | 12.97 (20.09%) | 10.8 (28.06%) | 8.43 (-1.41%) | 8.55 (6.65%) |
Tangible Assets Book Value Per Share (TABVPS) | 13.76 (21.91%) | 11.29 (20.60%) | 9.36 (-13.47%) | 10.82 (-10.34%) |
Enterprise Value Over EBIT (EV/EBIT) | -7 (63.16%) | -19 (-46.15%) | -13 (18.75%) | -16 (-60.00%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -6.79 (65.45%) | -19.67 (-39.74%) | -14.07 (18.51%) | -17.27 (-71.89%) |
Asset Turnover | 0.01 (-84.44%) | 0.04 (-66.91%) | 0.14 (74.36%) | 0.08 (-11.36%) |
Current Ratio | 14.97 (-23.83%) | 19.65 (68.27%) | 11.68 (110.15%) | 5.56 (-25.59%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$251,441,000 (-113.82%) | -$117,592,000 (-29.77%) | -$90,618,000 (-55.11%) | -$58,423,000 (-206.28%) |
Enterprise Value (EV) | $1,838,899,234 (-14.19%) | $2,142,993,014 (176.13%) | $776,086,313 (-3.85%) | $807,124,905 (142.59%) |
Earnings Before Tax (EBT) | -$274,477,000 (-142.98%) | -$112,961,000 (-92.59%) | -$58,655,000 (-17.87%) | -$49,762,000 (-44.26%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$270,643,000 (-148.40%) | -$108,953,000 (-97.59%) | -$55,140,000 (-18.00%) | -$46,730,000 (-41.12%) |
Invested Capital | $1,012,008,000 (116.56%) | $467,312,000 (60.59%) | $290,995,000 (16.76%) | $249,217,000 (28.32%) |
Working Capital | $643,642,000 (27.32%) | $505,531,000 (49.24%) | $338,736,000 (64.57%) | $205,837,000 (-17.65%) |
Tangible Asset Value | $1,124,091,000 (73.12%) | $649,316,000 (67.36%) | $387,969,000 (1.74%) | $381,347,000 (27.85%) |
Market Capitalization | $2,221,297,234 (-3.15%) | $2,293,468,014 (162.34%) | $874,222,313 (-3.94%) | $910,076,905 (123.62%) |
Average Equity | $1,026,633,500 (109.03%) | $491,139,500 (53.94%) | $319,053,000 (16.81%) | $273,132,250 (66.83%) |
Average Assets | $1,074,788,500 (107.23%) | $518,640,250 (38.70%) | $373,937,500 (4.21%) | $358,822,250 (62.00%) |
Invested Capital Average | $852,381,500 (127.80%) | $374,181,750 (41.55%) | $264,346,250 (20.90%) | $218,651,000 (86.81%) |
Shares | 86,431,799 (34.09%) | 64,459,472 (33.97%) | 48,113,501 (24.98%) | 38,497,331 (32.43%) |
